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Thelper17 (Th17) lymphocytes represent a third armof the CD4+ T-cell effector responses,
in addition to Th1 and Th2 cells. Th17 cells have been found to exhibit high plasticity
because they rapidly shift into the Th1 phenotype in inflammatory sites. In humans,
Th1 cells derived from Th17 cells express CD161, whereas classic Th1 cells do not; these
Th17-derived Th1 cells have been termed nonclassic Th1 cells. In this study, we exam-
ined similarities and differences between classic and nonclassic human Th1 cells by
assessing a panel of T-cell clones, as well as CD161+ or CD161− CD4+ T cells derived ex
vivo from the circulation of healthy subjects or the synovial fluid of patients with juvenile
idiopathic arthritis. The results show that nonclassic Th1 cells can be identified based on
CD161 expression, as well as the consistent expression of retinoic acid orphan receptor C,
IL-17 receptor E, CCR6, and IL-4-induced gene 1, which are all virtually absent in classic
Th1 cells. The possibility to distinguish these two-cell subsets by using such a panel of
markers may allow the opportunity to better establish the respective pathogenic roles
of classic and nonclassic (Th17 derived) Th1 cells in different chronic inflammatory
disorders.
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Introduction
CD4+ T helper (Th) cells can be classified into lineages on the basis
of cytokine production, the expression of specific transcription
factors, and the immunological function they mediate: Th1 cells,
which express the transcription factor T-box expressed in T cells
(T-bet) and secrete IFN-γ, protect the host against intracellular
infections; Th2 cells, which express GATA-3 and secrete IL-4, IL-5,
and IL-13, mediate host defense against helminths [1,2]. Recently,
additional subsets that preferentially produce distinct cytokines
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have been described. The most studied subset includes cells that
selectively produce IL-17A (Th17 cells), express the transcrip-
tion factor RAR-related orphan receptor (ROR)γt, and protect the
host against infection with extracellular pathogens [3,4]. Human
Th17 cells are, at least partially, different from murine Th17 cells
[5,6]. Indeed, human Th17 cells express not only distinctive Th17
molecules, such as IL-23 receptor (IL-23R) and RORC, but also
those typical of the Th1 phenotype such as IL-12Rβ2 and T-bet
[6]. Moreover, we have previously discovered a subset of human
Th17 cells that are also able to produce IFN-γ, named Th17/Th1
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cells; both Th17 and Th17/Th1 cells can be induced to become
Th1 cells when cultured in presence of IL-12 [6]. Similar find-
ings were then reported also in some murine models [7–9], thus
suggesting that both human and murine Th17 possess a plastic
phenotype [10,11].
Human IL-17-producing cells originate from CD161+ precur-
sors present in umbilical cord blood (UCB) and newborn thymus,
and maintain CD161 expression, which is detectable on memory
circulating and tissue-infiltrating Th17 and Th17/Th1 lympho-
cytes [12–14]. Moreover, Th1 cells that derive from Th17 cells
can be recognized in humans because of their expression, as Th17
cells, of CD161 [15]. The NK1.1 molecule, the murine equivalent
of CD161, has not been described in mouse Th17 cells.
Based on this finding, we have selected human CD161−
(classic) and CD161+ (nonclassic) Th1 cells and examined at both
clonal level and in ex vivo derived cells the main differences exist-
ing between them. The results showed that nonclassic Th1 cells
can be identified not only because of their CD161 expression, but
also because they consistently express RORC, IL-17RE, CCR6, and
IL-4-induced gene 1 (IL4I1), which are virtually absent in clas-
sic Th1 cells. The possibility to distinguish the two-cell subsets
by using this panel of markers offers the opportunity to better
establish their respective pathogenic roles in chronic inflamma-
tory disorders.
Results
Establishment of classic and nonclassic Th1 clones
Human Th17 cells are characterized by the surface expression
of CCR6, the IL-23 receptor (IL-23R), and CD161 [6, 12]. As
a consequence, a high proportion of clones derived from the
CD161+CCR6+ cell fraction of PBMCs from healthy donors, pro-
duced IL-17A alone or IL-17A plus IFN-γ, thus exhibiting a Th17
or Th17/Th1 phenotype, respectively. In a subsequent study
[16], we found that a proportion of clones generated from the
CD161+CCR6+ cell fraction showed the ability to produce IFN-γ
alone, i.e. they exhibited a Th1 phenotype, supporting the concept
that CD161 expression is a peculiar, but not exclusive, property
of the Th17 phenotype. Accordingly, we have recently demon-
strated the presence of CD161+ Th1 lymphocytes in the synovial
fluid (SF) of patients with juvenile idiopathic arthritis (JIA), that
derived from an in vivo shifting of Th17 to Th1 cells in presence
of IL-12 [15]. These cells were named nonclassic Th1 cells to dis-
tinguish them from the classic CD161− Th1 counterpart [15].
To investigate the main features of these two different Th1
subsets, CD4+CD161+ and CD4+CD161− T-cell populations were
purified from peripheral blood (PB) of healthy human subjects
and then cloned under limiting dilution conditions. As expected,
clones derived from the CD4+CD161+ T-cell fraction exhibited
a Th17, a Th17/Th1, or a Th1 phenotype, whereas virtually
all clones generated from the CD4+CD161− T-cell subset had a
Th1 phenotype and none of them was able to produce IL-17A
(Fig. 1A and B). CD161− Th1 clones were considered as classic
Th1 cells, whereas CD161+ Th1 cells were considered as non-
classic (Th17-derived) cells.
Transcription factors
The expression of the transcription factors T-bet and RORC by
classic and nonclassic Th1, as well as by Th17 or Th17/Th1, cells
were compared by assessing 20 randomly selected T-cell clones
from each phenotype with quantitative RT-PCR. In agreement
with previously published data [15,16], the Th1-related transcrip-
tion factor T-bet was found to be expressed by all four types of
T-cell clones analyzed, reaching the highest mRNA levels in both
classic and nonclassic-Th1 cells (Fig. 2A). By contrast, the Th17-
associated transcription factor RORC was distinctively expressed
by Th17, Th17/Th1, and nonclassic Th1, but not by classic Th1
clones (Fig. 2A).
Cytokine receptors
The expression of mRNA levels for cytokine receptors that have
been previously associated to Th17 cells, such as IL-23R, IL-1RI,
IL-12Rβ2, and IL-17RE [6, 12, 17], was also evaluated. As shown
in Figure 2B, mRNA levels for IL-23R and IL-1RI (the receptors
of two cytokines deeply involved in human Th17-cell differentia-
tion) were significantly higher in Th17, Th17/Th1, and nonclassic
Th1 when compared with that of classic Th1 cells, while IL-12Rβ2
mRNA levels were comparable in all four types of clones. Of note,
IL-1RI mRNA levels were significantly lower in nonclassic Th1 in
comparison to both Th17 and Th17/Th1 clones (Fig. 2B). Finally,
IL-17RE mRNA, a member of IL-17 receptor family, whose full-
length isoform is selectively expressed by murine Th17 cells and
potentiates their function in response to IL-17C [17], was clearly
detectable in Th17, Th17/Th1 and nonclassic Th1 clones, but vir-
tually absent in classic Th1 clones (Fig. 2B).
Chemokine receptors
In addition to transcription factors and cytokine receptors involved
in the differentiation/modulation of classic Th1 and Th17 cells,
some chemokine receptors have also been reported to be preferen-
tially associated with one or the other T-cell subset. In particular,
CXCR3A has been found to be expressed by Th1 cells [5], whereas
CCR6 preferentially associates with Th17 cells [5,6]. As shown in
Figure 3A, CCR6 mRNA expression was virtually absent in classic
Th1 cells, whereas it was expressed at comparable levels by Th17,
Th17/Th1, and nonclassic Th1 cells. Conversely, CXCR3A mRNA
levels were significantly higher in classic Th1 cells when compared
with those of Th17, Th17/Th1, and nonclassic Th1 cells (Fig. 3A).
Interestingly, CXCR3A expression was significantly lower in Th17
than in Th17/Th1 and nonclassic Th1 cells, the latter showing
significantly higher CXCR3A mRNA levels than Th17/Th1 cells
(Fig. 3A). Single-cell analysis of CXCR3A and CCR6 protein
expression performed by flow cytometry revealed that classic Th1
and Th17 cells had a clear CXCR3A and CCR6 single positive
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Figure 1. Cytokine profile of T-cell clones generated from the CD161+ and CD161− fraction of circulating CD4+ T cells. (A) CD161+ (n = 232) or
CD161− (n= 145) T-cell clones, derived from PB of three different donors, were stimulatedwith PMAplus ionomycin and assessed by flow cytometry
at single-cell level for their ability to produce IFN-γ and/or IL-17A. Red dots represent CD4+CD161+ clones and black dots represent CD4+CD161−
clones. Arrows indicate the four T-cell clones depicted in panel B. (B) A representative flow cytometric analysis of each Th-cell population shown
in panel A (classic and nonclassic Th1, Th17, Th17/Th1 clones) is depicted.
phenotype, respectively; Th17/Th1 cells comprised of both CCR6
single positive and CXCR3A+CCR6+ double positive phenotypes;
nonclassic Th1 were mainly characterized by a CXCR3A+CCR6+
double positive phenotype (Fig. 3B).
IL4I1 expression and proliferative response
Th17 cells, differently from Th1 cells, show poor proliferative
responses to anti-CD3 plus anti-CD28 stimulation, mainly because
of their inability to produce IL-2 [18]. This defect in IL-2 pro-
duction is due to the reduced c-Fos, c-Jun, and nuclear factor of
activated T-cells activity. The reduced activity of these transcrip-
tion factors associated with high expression of the IL4I1 mRNA,
which encodes for an L-phenylalanine oxidase able to downregu-
late CD3ζ expression in T cells [19]. As shown in Figure 4A, IL4I1
mRNA was expressed not only by Th17, but also by Th17/Th1 and
by nonclassic Th1 cells, but never by classic Th1 cells. In order to
establish whether nonclassic Th1 cells also exhibited poor, if any,
proliferative response to TCR triggering that is characteristic of
Th17 cells, 20 clones of each of the four different Th pheno-
types (Th17, Th17/Th1, and classic and nonclassic Th1 cells)
were stimulated in vitro for 5 days with anti-CD3 plus anti-CD28
mAbs and their proliferative response was assessed. In accordance
with previously published results [18], Th17 clones showed sig-
nificantly reduced ability, when compared with classic Th1 cells,
to proliferate in response to TCR triggering (Fig. 4B). Nonclas-
sic Th1 cells showed a significantly higher proliferative response
to TCR triggering when compared with Th17 cells, but signifi-
cantly lower than classic Th1 cells. As expected, Th17/Th1 cells
exhibited a proliferative response comparable to that of Th17 cells
(Fig. 4B). Finally, in order to exclude any link between the fre-
quency of cytokine-producing cells of the different clones and
cell proliferation, correlation between the level of 3H uptake in
response to anti-CD3 plus anti-CD28 in the presence or absence
of IL-2, and the frequency of IFN-γ- and IL-17-producing cells was
performed. As shown in Figure 4C, no significant correlation was
present between the frequency of cytokine-producing cells and the
degree of proliferation for any of the Th-cell subsets analyzed.
Differences between classic and nonclassic Th1 clones
detectable on ex vivo derived cells
In order to exclude the possibility that all these findings were an
artifact due to the use of long-term in vitro cultured T cells (T-cell
clones), the mRNA levels of all the above-mentioned molecules
were also measured on ex vivo derived IFN-γ-producing T cells,
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Figure 2. Transcription factor and cytokine receptor mRNA expression by classic, nonclassic Th1, Th17/Th1, and Th17 clones. (A) T-bet and RORC
and (B) IL-12Rβ2, IL-23R, IL-1RI, and IL-17RE mRNA expression by classic (n = 15) and nonclassic Th1 (n = 15), Th17 (n = 15) and Th17/Th1 (n = 15)
clones was evaluated by real-time quantitative RT-PCR. Results were normalized to GAPDH mRNA and shown as mean values + SE. Data shown
were obtained in three different experiments. A standard two-tailed unpaired t-test was used for statistical analysis.
which had been purified from the sorted CD161+ (nonclassic Th1
cells) and CD161− (classic Th1 cells) PB CD4+ T-cell fractions
by capture secretion assay, as already reported [15]. In agree-
ment with data obtained using T-cell clones, ex vivo derived non-
classic Th1 cells could be clearly distinguished from classic Th1
cells not only for their expression of CD161, but also of RORC,
IL-17RE, CCR6, and IL4I1 (Fig. 5A). Moreover, comparable results
were obtained when the above-mentioned markers in classic and
nonclassic Th1 cells isolated from SF of three JIA patients were
evaluated (Fig. 5B).
Discussion
Classically, Th1 cells have been defined as effector Th cells that
secrete IFN-γ but not IL-4, express the transcription factor T-bet
and protect the host against intracellular infections [1,2]. Th1 cells
have also been thought to be involved in chronic inflammation,
both in murine experimental models and human diseases, espe-
cially organ-specific autoimmune disorders [1,2]. Classic Th1 cells
can be derived in vitro and in vivo from na¨ıve Th cells under condi-
tions characterized by the presence of IL-12, IL-18, and IFNs, and
in absence of IL-4 [20]. More recently, a new lineage of effector
CD4+ Th cells has been described that selectively produces IL-17A
(Th17 cells), expresses the transcription factor RORγt and is criti-
cal for the host defense against extracellular pathogens [3,4]. This
subset has been initially thought to be pathogenic in many chronic
inflammatory disorders, including both experimental animal mod-
els and human autoimmune disorders [6,12,15,21]. According to
findings mainly obtained in models of knockout mice [22–24], and
also because of the counteracting activity of IFN-γ on the devel-
opment of Th17 cells [3], Th1 cells were thought to be rather
protective than pathogenic in the same disorders [3]. Our group
was the first to demonstrate that part of human IL-17A-producing
cells were also able to produce IFN-γ, and more importantly, to
provide evidence that human Th17 cells exhibit plasticity and can
be shifted to produce IFN-γ in presence of IL-12 [6]. The shifting
of Th17 cells toward the Th1 phenotype was then demonstrated
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Figure 3. Chemokine receptors expression by classic and nonclassic Th1, Th17/Th1, and Th17 clones. (A) CCR6 and CXCR3A mRNA expression
by classic (n = 15) and nonclassic Th1 (n = 15), Th17 (n = 15), and Th17/Th1 (n = 15) clones was evaluated by real-time quantitative RT-PCR.
Results were normalized to GAPDHmRNA and shown as mean values + SE. A standard two-tailed unpaired t-test was used for statistical analysis.
(B) CCR6 and CXCR3A protein expression by classic (n = 9) and nonclassic Th1 (n = 9), Th17 (n = 9), and Th17/Th1 (n = 9) clones was evaluated
by flow cytometry and shown as mean values + SE. A standard two-tailed unpaired t-test was used for statistical analysis. A representative flow
cytometric analysis of each Th-cell population (classic and nonclassic Th1, Th17, Th17/Th1 clones) is depicted (bottom).
even in different murine experimental models and the concept
of Th17-cell plasticity now represents an established fact in both
species [10, 11]. In a recent study, we found that Th17 cells are
rare in the SF of patients with JIA whereas Th1 cells were highly
predominant, which was at least partially due to the property of
Th17 cells to shift into Th1 cells in presence of IL-12 [15]. The
Th17-derived Th1 cells expressed CD161, while the other Th1
cells present in the SF did not, and we named the former cells as
nonclassic, as compared with classic CD161− Th1 cells [15]. How-
ever, the similarities and differences between classic and nonclas-
sic (Th17-derived) Th1 cells were not extensively investigated.
More recently, we also demonstrated the existence of another
mechanism responsible for the rarity of Th17 cells in inflamed tis-
sues. Indeed we showed that Th17 lymphocytes are, on one hand
unable to proliferate in response to TCR triggering due to abnor-
malities in the molecular pathways that allow IL-2 production,
and, on the other hand, possessed a reduced ability to respond to
IL-2 [18]. The inability of Th17 cells to produce IL-2 in response
to TCR triggering appeared to be related to the upregulation
of the L-amino acid oxidase IL4I1 which, in turn, was strictly
dependent on the activity of the Th17 master gene, RORC [18].
Based on all these findings, in this study, we investigated and
compared the similarities and differences among Th17 cells, clas-
sic Th1 cells, and nonclassic Th1 cells. In order to approach this
question, we took advantage from our previous observation that
human Th17 cells all are contained in a subset of memory Th cells
that express CD161 (or NKR-P1A), the human homologue of the
murine NK1.1 [12,14], which is not only expressed on almost all
NK cells, but also on a subset of T cells, which have been named
NKT cells [25]. In contrast, murine Th17 cells do not seem to
exhibit such a marker. More importantly, in the same study, we
also found that human Th17 cells originate from a small subset
of thymic CD161+ precursors, which also express RORC, which
in turn is critical for CD161 expression, whereas Th17 cells could
never have been derived from CD161− Th cells [12,14]. We there-
fore evaluated the expression of different cytokines, transcription
factors, cytokine and chemokine receptors, as well as the expres-
sion of IL4I1 and the ability to proliferate in response to TCR
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Figure 4. IL4I1 mRNA expression and proliferation in response to anti-CD3 plus anti-CD28 stimulation of classic and nonclassic Th1, Th17/Th1,
and Th17 clones. (A) IL4I1 mRNA expression by classic (n = 15) and nonclassic Th1 (n = 15), Th17 (n = 15), and Th17/Th1 (n = 15) clones was
evaluated by real-time quantitative RT-PCR. Results were normalized to GAPDH mRNA and shown as mean values + SE. (B) Classic (n = 20) and
nonclassic Th1 (n = 20), Th17 (n = 20), and Th17/Th1 (n = 20) clones were stimulated with anti-CD3 plus anti-CD28 and then assessed on day 5
for proliferation by evaluating 3H-TdR uptake. Data are shown as mean values + SE. Data shown were obtained in four different experiments. A
standard two-tailed unpaired t-test was used for statistical analysis. (C) Classic and nonclassic Th1 clones and Th17 clones were evaluated for IFN-γ
and IL-17 production at single-cell level upon 5 h activation with PMA plus ionomycin and assessed for proliferation upon stimulation with anti-
CD3 plus anti-CD28, in absence or presence of IL-2, on day 5 by evaluating 3H-TdR uptake. Correlation between frequencies of cytokines-producing
cells and 3H-TdR uptake was performed by using Pearson’s correlation coefficient.
triggering, by classic Th1 T-cell clones derived from CD161− cir-
culating CD4+ T cells from healthy donors and nonclassic Th1, as
well as Th17 and Th17/Th1 clones, derived from CD161+CD4+
T cells from the same donors. The results show that nonclassic
Th1 cells, differently from classic Th1 cells, express the majority
of typical Th17-associated molecules. In particular, in addition
to CD161, nonclassic Th1 cells express the master transcription
factor for Th17 cells RORC, the chemokine receptor CCR6, the
cytokine receptor IL-17RE and IL4I1. At the same time, nonclassic
Th1 cells show increased expression of some classic Th1-associated
molecules. In particular, in addition to IFN-γ, nonclassic Th1 cells
showed increased expression of T-bet, the master transcription
factor for Th1 cells, which has been found to be expressed also by
Th17 cells [6], as well as of IL-12Rβ2, and acquire the ability to
express CXCR3A. The data obtained at clonal level were confirmed
not only on classic and nonclassic Th1 cells freshly isolated from
the circulation of healthy subjects, but also from CD4+ T cells from
the SF of children affected by JIA.
Thus, the results of the present study provide convincing evi-
dence that nonclassic Th1 cells can be easily distinguished from
classic Th1 cells by using a combination of the surface markers
CD161, CCR6, CXCR3A, and IL-17RE, as well as by their abil-
ity to express RORC and IL4I1. These findings are of particu-
lar relevance because the possibility to easily distinguish classic
from nonclassic (Th17 derived) Th1 cells may allow to define
the role of these Th-cell subsets in the pathogenesis of chronic
inflammatory disorders. Indeed, these disorders have been in
the past associated to Th1 responses and more recently to Th17
cells, even because of the ability of the latter to polarize toward
the Th1 phenotype. Accordingly, increased numbers of nonclassic
Th1 cells are present not only in the inflamed joints (SF) of JIA chil-
dren [15], but also in the gut of Crohn’s disease affected patients
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Figure 5. Differences between classic and nonclassic Th1 clones are also present on ex vivo-derived cell subsets from both PB of healthy donors
and SF of JIA patients (A) PB of healthy subjects (n = 3) and (B) SF of JIA patients (n = 3) were stimulated with PMA plus ionomycin, and sorted
by FACS into CD3+CD4+CD8−CD161−IL-17−IFN-γ+ (classic Th1) and CD3+CD4+CD8−CD161+IL-17−IFN-γ+ (nonclassic Th1) cells. On day 7, each
cell fraction was assessed for T-bet, RORC, IL4I1, IL-12Rβ2, IL-23R, IL-1RI, IL-17RE, CCR6, and CXCR3A, mRNA expression by real-time quantitative
RT-PCR. Results were normalized to GAPDH mRNA and shown as mean values + SE. Data were obtained in three different experiments. *p < 0.05;
**p < 0.01; a standard two-tailed unpaired t-test was used for statistical analysis.
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[12], the numbers of Th17 cells in both sites being very usually
low [12,15].
One intriguing question emerging from this study was the
demonstration that despite nonclassic Th1 cells maintained the
IL4I1 expression at levels similar to those of Th17 cells, they
showed an increased ability to proliferate in response to TCR trig-
gering, a condition which was more similar to that of classic Th1
cells. This finding can account for the high number of nonclas-
sic Th1 cells in inflamed tissues, but the reason why nonclassic
Th1 cells at least partially re-acquire the ability to proliferate,
still mantaining significantly higher mRNA levels of RORC and
IL4I1 when compared with classic Th1 cells, is at present unclear.
One possibility is that the inability of Th17 cells to expand is also
due to abnormalities other than those related to the upregula-
tion of IL4I1. In our previous study, we showed indeed that Th17
cells also exhibit a block in the activation of PI3K/AKT pathway
in response to IL-2 [18]. Therefore, the existence of additional
inhibitory mechanisms cannot be excluded and their changes fol-
lowing the shifting of Th17 cells into nonclassic Th1 cells, leading
to better expansion of these latter, might be hypothesized.
In conclusion, the results of this study demonstrate that non-
classic (Th17-derived) Th1 cells can be clearly distinguished from
classic Th1 cells in both the circulation and in inflamed tissues by
using a panel of different markers. This finding may be of great
help in better understanding the respective pathogenic roles of
nonclassic and classic Th1 cells in several chronic inflammatory
disorders, thus allowing more appropriate therapeutical interven-
tions.
Materials and methods
Subjects
PB samples were obtained from eight healthy volunteers. The pro-
cedures and all the experiments of the study were in accordance to
the ethical standards of and approved by the Regional Committee
on Human Experimentation. SF samples were also obtained from
three children affected by oligoarticular JIA according to the ILAR
classification.
Reagents
The culture media used was RPMI 1640 (Seromed) supplemented
with 2 mM L-glutamine, 1% nonessential amino acids, 1% sodium
pyruvate, 2 × 10−5 M 2-mercaptoethanol (2-ME; all from Invitro-
gen), and 10% FBS HyClone (Gibco Laboratories, Grand Island,
NY, USA). Unlabeled or fluorochrome-conjugated anti-CD3, CD4,
CD8, CD28, CD161, CCR6, IFN-γ, and isotype-matched con-
trol mAb were purchased from BD Biosciences (San Jose, CA,
USA). The fluorochrome-conjugated anti-IL-17 mAb was obtained
from eBioscience (San Diego, CA, USA) and the fluorochrome-
conjugated anti-CXCR3 mAb was obtained from R&D Systems
(Minneapolis, MN, USA). PMA, ionomycin and brefeldin A were
purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Establishment of T-cell clones and their
characterization
CD4+ T cells, derived from PBMNCs of four healthy donors by
using the CD4 isolation kit II (Miltenyi Biotec, Bergisch Glad-
bach), were further divided into CD161+ and CD161− T-cell frac-
tion by staining with an anti-CD161–PE mAb, followed by incuba-
tion with an anti-PE microbead mAb (Miltenyi Biotec). Then the
two-cell subsets CD4+CD161+ and CD4+CD161− were cultured
under limiting dilution (0.3 cell/well) in presence of 105 irradiated
(9000 rad) allogeneic PBMCs as feeder cells, 1% PHA (vol/vol),
and 50 U/mL rIL-2 (Proleukin, Prometheus, Inc., San Diego, USA),
in order to obtain T-cell clones. Recovered CD4+ T-cell clones were
classified on the basis of their ability to produce IFN-γ and/or
IL-17 and to express surface marker CD161, as previously
described [16]. Briefly, T cells were polyclonally stimulated with
PMA plus ionomycin, fixed in formaldehyde and then analyzed for
intracellular cytokines production on a BDLSR II flow cytometry
(BD Biosciences). Selected T-cell clones of each phenotype were
further analyzed by flow cytometry for surface expression of
CXCR3A and CCR6.
Proliferation assay
A total of 5 × 104 cells of selected T-cell clones of each phe-
notype were stimulated for 3 days with 5 μg/mL anti-CD3 plus
5 μg/mL anti-CD28 mAb (BD Biosciences), to evaluate their pro-
liferative response. Cultures were pulsed for the last 8 h with
0.5 μCi (0.0185 MBq) of 3H-TdR (GE Healthcare), harvested, and
radionuclide uptake was measured by scintillation counting.
Cytokine secretion assay and cell culture
MNC from PB of three healthy donors and from SF of three
JIA patients were stimulated with PMA plus ionomycin. After
three and half hours, stimulated cells were recovered, washed,
and stained with IFN-γ and IL-17 catch reagents (Miltenyi
Biotec), following manufacturer instructions. Following addi-
tional 45 min of incubation (37◦C, 5% CO2) cells were stained
with anti-CD3-Pacific Blue, CD4-PE-Cy7, CD8-allophycocyanin-
Cy7, CD161-PE, IL-17-allophycocyanin, and IFN-γ-FITC conju-
gated mAbs, analyzed and sorted by FACSAria (BD Biosciences)
into CD3+CD4+CD8−CD161+IL-17−IFN-γ+ (nonclassic Th1) and
CD3+CD4+CD8−CD161−IL-17−IFN-γ+ (classic Th1), cells. The
recovered cells were cultured for 1 week in presence of IL-2
(50U/mL) and then analyzed for the expression of mRNA levels
of RORC, IL-17RE, CCR6, and IL4I1.
Real-time quantitative RT-PCR
Taq-Man RT-PCR was performed, as described elsewhere
[10,12]. Primers and probes used were from Applied Biosystems
(Foster City, CA, USA). Quantitative PCR analysis of CXCR3A
was performed by using the following: FAM probe, 5′-TGAGTGA
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CCACCAAGTGCTAAATGACGC-3′; forward 5′-ACCCAGCAGCCAG
AGCACC-3′; reverse 5′-TCATAGGAAGAGCTGAAGTTCTCCA-3′,
were from Applied Biosystems.
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